memo - Magazine of European Medical Oncology 1/2020

Prof. Helmut H. Popper M.D., Ulrike Gruber-Mösenbacher, Georg Pall, Leonhard Müllauer, Maximilian Hochmair, Dagmar Krenbek, Luka Brcic, Katja Schmitz, Bernd Lamprecht, Josef Eckmayr, Wolfgang Hilbe, Georg Hutarew, Peter Errhalt, Rainer Kolb, Robert Pirker, Ulrike Setinek, Gerald Webersinke, Gudrun Absenger, Tamara Hernler, Markus Rauter, Richard Wasicky

20.02.2020 | special report | Ausgabe 1/2020 Open Access

Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network

Univ. Prof. Dr. Hildegard T. Greinix, Univ. Prof. Dr. Andishe Attarbaschi, Dr. Michael Girschikofsky, Univ. Prof. Dr. Richard Greil, Univ. Prof. Dr. Wolfgang Holter, Univ. Prof. Dr. Peter Neumeister, Univ. Prof. Dr. Christina Peters, Univ. Prof. Dr. Andreas Petzer, Dr. Jakob Rudzki, Univ. Prof. Dr. Peter Schlenke, Univ. Prof. Dr. Clemens A. Schmitt, Univ. Prof. Dr. Wolfgang Schwinger, Univ. Prof. Dr. Dominik Wolf, Univ. Prof. Dr. Nina Worel, Univ. Prof. Dr. Ulrich Jaeger

PDF-Version jetzt herunterladen Zum Volltext

24.01.2020 | short review | Ausgabe 1/2020 Open Access

CAR T-cell therapy in diffuse large B-cell lymphoma

PD Dr. Georg Hopfinger, Univ. Prof. Dr. Nina Worel

PDF-Version jetzt herunterladen Zum Volltext

14.11.2019 | review | Ausgabe 1/2020 Open Access

Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia

Univ. Prof. Dr. Hildegard T. Greinix

PDF-Version jetzt herunterladen Zum Volltext

16.01.2020 | short review | Ausgabe 1/2020 Open Access

CAR-T cells in multiple myeloma: current status

PD Dr. Normann Steiner, Univ.-Doz. Dr. Eberhard Gunsilius

PDF-Version jetzt herunterladen Zum Volltext

05.02.2020 | short review | Ausgabe 1/2020 Open Access

AML—is it time to drive a CAR(-T)?

Dr. Jakob D. Rudzki, Dominik Wolf

PDF-Version jetzt herunterladen Zum Volltext

04.02.2020 | review | Ausgabe 1/2020

Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma

Dr. Thomas Spanberger

24.10.2019 | short review | Ausgabe 1/2020

Evidence-based follow-up for breast cancer

Short review

Michael Stierer

12.12.2019 | short review | Ausgabe 1/2020 Open Access

Evidence-based follow-up in colorectal cancer—quo vadis?

Assoc. Prof. Priv.-Doz. Dr. Manuel Maglione MBA MCI, FEBS (HPB), Assoc. Prof. Priv.-Doz. Dr. Alexander Perathoner

PDF-Version jetzt herunterladen Zum Volltext

23.01.2020 | short review | Ausgabe 1/2020

Evidence-based follow-up in non-small cell lung cancer

Stefan B. Watzka MD, BA, FACS

23.01.2020 | short review | Ausgabe 1/2020 Open Access

Evidence-based follow-up in lung cancer?

Focusing on the risk group of recently operated patients

Caecilia Ng, Andreas Pircher, Florian Augustin, Florian Kocher MD PhD

PDF-Version jetzt herunterladen Zum Volltext

11.11.2019 | short review | Ausgabe 1/2020

Evidence-based follow-up in renal cell carcinoma

Karl Mayrhofer MD, Dora Niedersüß-Beke MD, MBA

09.01.2020 | short review | Ausgabe 1/2020

Importance of avoiding late cancer-directed therapy in terminally ill cancer patients

Dr. Daniela Jahn-Kuch MSc

16.01.2020 | short review | Ausgabe 1/2020

The top ten things that must be known about end of life therapy in patients with advanced cancer

Gudrun Kreye, Bettina Heidecker, Eva K. Masel

20.01.2020 | short review | Ausgabe 1/2020

Palliative sedation for delirium management at the end of life

Sophie Roider-Schur

09.01.2020 | short review | Ausgabe 1/2020 Open Access

While I breathe, I hope. Principles of palliative care in chronic breathlessness and advanced lung diseases

Eva Katharina Masel MD, PhD, MSc

PDF-Version jetzt herunterladen Zum Volltext

15.01.2020 | case report | Ausgabe 1/2020 Open Access

Complete remission of disseminated Langerhans cell sarcoma after stem cell transplantation

A case report

Verena Schlintl, Konstantin Schlick, Gudrun Russ, Simon Peter Gampenrieder, Claudia Monzo Fuentes, Tea Kos, Felix Renneberg, Lukas Rettenbacher, Johann Gradl, Karl Sotlar, Alexander Hoffmann, Univ. Prof. Dr. Richard Greil

PDF-Version jetzt herunterladen Zum Volltext

08.01.2020 | short review | Ausgabe 1/2020 Open Access

Cutaneous squamous cell carcinoma

Risk factors and new systemic treatment options in advanced disease

Magdalena Seidl-Philipp, Van Anh Nguyen

PDF-Version jetzt herunterladen Zum Volltext

14.11.2019 | original report | Ausgabe 1/2020

Epidemiology of polycythemia vera in a Mexican population

Clinical presentation, vascular complications, and survival among a 90-patient cohort from a single center

Antonio Olivas-Martinez, Olga Barrales-Benítez, Daniel Montante-Montes-de-Oca, Diana Aguilar-León, Hilda Elizeth Hernández-Juárez, Elena Tuna-Aguilar

09.01.2020 | original report | Ausgabe 1/2020

Epidemiology and predictors of survival of tongue cancer among Egyptians in the Delta region

Omar Hamdy, Mahmoud M. Saleh, Mohammed H. Ros, Amir Mosaad, Shadi Awny, Engy M. Abo-Elnaga, Islam H. Metwally

31.01.2020 | original report | Ausgabe 1/2020 Open Access

Incidental thyroid papillary microcarcinoma on 1777 surgically treated patients for benign thyroid disease

A monoinstitutional experience and literature review

Gaia Peluso, Stefania Masone, Silvia Campanile, Carmen Criscitiello, Concetta Dodaro, Armando Calogero, Paola Incollingo, Gianluca Minieri, Marsela Menkulazi, Alessandro Scotti, Vincenzo Tammaro, Ali Akbar Jamshidi, Luigi Pelosio, Marcello Caggiano, Nicola Carlomagno, Michele L. Santangelo

PDF-Version jetzt herunterladen Zum Volltext

memo - Magazine of European Medical Oncology

Ausgabe 1/2020

Inhaltsverzeichnis ( 26 Artikel )

The golden anniversary of the Austrian Society of Hematology and Medical Oncology (OeGHO)

CAR(-T)s are on the road

Evidence-based follow-up

End-of-life therapy: palliative care instead of palliative scare

Young hematologists and medical oncologists in focus

The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers

Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network

CAR T-cell therapy in diffuse large B-cell lymphoma

Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia

CAR-T cells in multiple myeloma: current status

AML—is it time to drive a CAR(-T)?

Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma

Evidence-based follow-up for breast cancer

Evidence-based follow-up in colorectal cancer—quo vadis?

Evidence-based follow-up in non-small cell lung cancer

Evidence-based follow-up in lung cancer?

Evidence-based follow-up in renal cell carcinoma

Importance of avoiding late cancer-directed therapy in terminally ill cancer patients

The top ten things that must be known about end of life therapy in patients with advanced cancer

Palliative sedation for delirium management at the end of life

While I breathe, I hope. Principles of palliative care in chronic breathlessness and advanced lung diseases

Complete remission of disseminated Langerhans cell sarcoma after stem cell transplantation

Cutaneous squamous cell carcinoma

Epidemiology of polycythemia vera in a Mexican population

Epidemiology and predictors of survival of tongue cancer among Egyptians in the Delta region

Incidental thyroid papillary microcarcinoma on 1777 surgically treated patients for benign thyroid disease

Ausgabe 3/2020

Sonderheft 3/2020

Ausgabe 2/2020

Sonderheft 2/2020

Ausgabe 1/2020

Sonderheft 1/2020

Sonderheft 4/2019

Ausgabe 4/2019

Ausgabe 3/2019

Sonderheft 3/2019

Springer Medizin Österreich

Inhaltsverzeichnis ( 26 Artikel )

The golden anniversary of the Austrian Society of Hematology and Medical Oncology (OeGHO)

CAR(-T)s are on the road

Evidence-based follow-up

End-of-life therapy: palliative care instead of palliative scare

Young hematologists and medical oncologists in focus

The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers

Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network

CAR T-cell therapy in diffuse large B-cell lymphoma

Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia

CAR-T cells in multiple myeloma: current status

AML—is it time to drive a CAR(-T)?

Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma

Evidence-based follow-up for breast cancer

Evidence-based follow-up in colorectal cancer—quo vadis?

Evidence-based follow-up in non-small cell lung cancer

Evidence-based follow-up in lung cancer?

Evidence-based follow-up in renal cell carcinoma

Importance of avoiding late cancer-directed therapy in terminally ill cancer patients

The top ten things that must be known about end of life therapy in patients with advanced cancer

Palliative sedation for delirium management at the end of life

While I breathe, I hope. Principles of palliative care in chronic breathlessness and advanced lung diseases

Complete remission of disseminated Langerhans cell sarcoma after stem cell transplantation

Cutaneous squamous cell carcinoma

Epidemiology of polycythemia vera in a Mexican population

Epidemiology and predictors of survival of tongue cancer among Egyptians in the Delta region

Incidental thyroid papillary microcarcinoma on 1777 surgically treated patients for benign thyroid disease

Aktuelle Ausgaben

Ausgabe 3/2020

Sonderheft 3/2020

Ausgabe 2/2020

Sonderheft 2/2020

Ausgabe 1/2020

Sonderheft 1/2020

Sonderheft 4/2019

Ausgabe 4/2019

Ausgabe 3/2019

Sonderheft 3/2019